SHF Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on November 6, 2025, regarding a Special Meeting of stockholders held by SHF Holdings, Inc. The filing was signed on November 10, 2025. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. No financial statements are included in this document.
Material Changes and Corporate Actions
Stockholders approved six key proposals at the Special Meeting:
- Authorized Shares Increase: The number of authorized common shares was increased from 130,000,000 to 1,000,000,000.
- SPA Issuance Approval: Ratified the issuance of shares upon conversion of 31,052 Series B Convertible Preferred Stock shares and exercise of warrants for up to 1,999,543 shares (exercise price $7.7644).
- CREO Issuance Approval: Ratified the issuance of common stock to CREO Investments LLC pursuant to a September 17, 2025, Common Stock Purchase Agreement.
- Management Participation: Approved management and director participation in certain common stock offerings under Nasdaq Listing Rule 5635(c).
- Reverse Stock Split Authority: Granted the Board authority to effect a reverse stock split between 2-for-1 and 12-for-1.
- Adjournment: Approved the adjournment of the Special Meeting.
Voting Results Summary
| Proposal | For | Against | Abstain |
|---|---|---|---|
| Authorized Shares Amendment | 1,541,096 | 94,319 | 6,241 |
| SPA Issuance Proposal | 1,588,199 | 47,151 | 6,306 |
| Common Stock Issuance (CREO) | 1,587,886 | 47,264 | 6,506 |
| Management Participation | 1,601,289 | 34,429 | 5,938 |
| Reverse Stock Split Authority | 1,595,746 | 39,796 | 6,114 |
| Adjournment | 1,591,205 | 44,150 | 6,301 |
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the standard disclosures regarding the proposed corporate actions. The Company filed a press release regarding the meeting results as Exhibit 99.1, which is furnished but not deemed "filed" for liability purposes.
Investor Verification Checklist
- Verify the exact terms of the Common Stock Purchase Agreement with CREO Investments LLC to understand potential dilution.
- Monitor future Board announcements regarding the specific ratio and timing of the authorized reverse stock split (2-for-1 to 12-for-1).
- Review the Definitive Proxy Statement filed on October 24, 2025, for detailed descriptions of the Authorized Shares Amendment.
- Confirm the impact of the Series B Preferred Stock conversion and warrant exercises on the total share count.